$14.00Peak — highest point inside the window, not a realized return
$13.66Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 14 days.
At window close
+94%
realized, from the publication price to the last close inside the window
Peak gain
+98.9%
peak, from the publication price — not a realized return
S&P 500, same window
+5.9%
SPY over the identical days, dividend-adjusted
Window close
$13.66
last close inside the window, ended September 8, 2026
Peak price
$14.00
peak on August 27, 2026 — not a realized return
Days to target
14
The thesis — published June 10, 2026
Predicted growth
+22%
over the measurement window
Target price
$8.59
the price the thesis aimed for
Entry zone
$6.60 – $7.10
the fair-value band we waited for
Price at publication
$7.04
published June 10, 2026
Confidence
74%
how strongly the data lined up
Timeframe
Short-term (0–3 months)
Aveanna looks interesting because it keeps beating earnings and just bought Family First Homecare, which makes the company bigger in home-based care. Demand for care at home should help results. But the company carries a lot of debt and its stock can swing widely, so gains are possible but not guaranteed while integration and balance-sheet risk remain.
Primary drivers
Acquisition of Family First boosts size in home-based care
Consistent earnings results point to improving operations
Valuation is low, offering upside if debt stays under control
Growing demand for home-health services supports revenue
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.